The Absorption, Metabolism and Excretion of [14C]Ensartinib in Human
Condition(s):ALK-POSITIVE NSCLCLast Updated:January 15, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):ALK-POSITIVE NSCLCLast Updated:January 15, 2019Unknown status
Condition(s):Solid Tumor; Non-Small Cell Lung Cancer MetastaticLast Updated:August 21, 2023Completed
Condition(s):Non-small Cell Lung CancerLast Updated:October 10, 2023Recruiting
Condition(s):MelanomaLast Updated:February 2, 2024Active, not recruiting
Condition(s):Lung Cancer, Nonsmall Cell; Brain MetastasesLast Updated:June 4, 2020Unknown status
Condition(s):Non-Small Cell Lung CancerLast Updated:August 8, 2022Not yet recruiting
Condition(s):Carcinoma, Non-Small-Cell Lung; Anaplastic Lymphoma Kinase I1171N; EnsartinibLast Updated:August 11, 2022Recruiting
Condition(s):Non-small Cell Lung Cancer; Carcinoma; NSCLCLast Updated:October 10, 2022Completed
Condition(s):Non Small Cell Lung CancerLast Updated:August 18, 2022Recruiting
Condition(s):Non-Small Cell Lung CancerLast Updated:July 24, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.